CureZone   Log On   Join
Plerixafor Injection 24 mg/1.2 ml: As a Mobilising Agent
marykudro Views: 105
Published: 81 days ago

Plerixafor Injection 24 mg/1.2 ml: As a Mobilising Agent

Plerixafor injection 24 mg/1.2 ml mainly is a hematopoietic stem cell mobilizer, helps bone marrow release stem cells in the bloodstream so they can be gathered and transplanted back into the body. The plerixafor injection 24 mg/1.2 ml is used in individuals with NHL (non-Hodgkin's lymphoma) or MM-multiple myeloma. Treatment with Plerixafor should be started after the patient has received G-CSF once daily for four days. Administer Plerixafor approximately 11 hours prior to initiation of each apheresis for up to 4 consecutive days. The recommended dosage of Plerixafor should be administered by subcutaneous injection and should be based on the body weight.


Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


Donate to CureZone

CureZone Newsletter is distributed in partnership with

Contact Us - Advertise - Stats

Copyright 1999 - 2022

1.391 sec, (1)